close
close
who owns galleri blood test

who owns galleri blood test

less than a minute read 30-12-2024
who owns galleri blood test

Who Owns the Galleri Blood Test?

The Galleri blood test, a groundbreaking multi-cancer early detection test, is developed and marketed by Grail, Inc. Grail was originally a subsidiary of Illumina, a leading developer of DNA sequencing technology. However, Illumina no longer owns Grail. In 2021, Illumina was ordered by a US court to divest from Grail, leading to a complex ownership structure.

While Illumina's ownership stake ended, the exact current ownership of Grail and therefore the Galleri test is spread across various investors and stakeholders. This includes:

  • Private Equity Firms: A significant portion of Grail's ownership is now held by a variety of private equity firms that invested in the company after the court-ordered divestment from Illumina. The exact breakdown of these holdings isn't publicly available in a readily accessible form.
  • Other Investors: Grail has also attracted investments from other sources, contributing to the complex ownership picture. Information on these investors may be found in Grail's financial filings, if publicly available.

Why is the ownership structure complicated?

The separation of Grail from Illumina was a result of antitrust concerns. The merger between Illumina and Grail was deemed potentially anti-competitive by regulators, limiting Illumina's dominance in the rapidly developing field of cancer detection technologies. This legal battle significantly impacted Grail's ownership structure, leading to its current, less transparent status.

Where to find more information:

For the most accurate and up-to-date information on the ownership of Grail and the Galleri blood test, it's best to consult these resources:

  • Grail's official website: Their "About Us" section might provide information on key investors or partnerships.
  • Securities and Exchange Commission (SEC) filings: If Grail is a publicly traded company, its SEC filings will disclose ownership information.
  • Financial news sources: Major financial news outlets often report on significant changes in company ownership.

In short, while Grail originally stemmed from Illumina, the current ownership of the Galleri blood test is a complex matter involving multiple private equity firms and other investors, making a definitive, easily accessible answer difficult to obtain. The information above points to where you can potentially find more precise details.

Related Posts


Latest Posts